Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 103

1.

Genetic Etiology for Alcohol-Induced Cardiac Toxicity.

Ware JS, Amor-Salamanca A, Tayal U, Govind R, Serrano I, Salazar-Mendiguchía J, García-Pinilla JM, Pascual-Figal DA, Nuñez J, Guzzo-Merello G, Gonzalez-Vioque E, Bardaji A, Manito N, López-Garrido MA, Padron-Barthe L, Edwards E, Whiffin N, Walsh R, Buchan RJ, Midwinter W, Wilk A, Prasad S, Pantazis A, Baski J, O'Regan DP, Alonso-Pulpon L, Cook SA, Lara-Pezzi E, Barton PJ, Garcia-Pavia P.

J Am Coll Cardiol. 2018 May 22;71(20):2293-2302. doi: 10.1016/j.jacc.2018.03.462.

2.

Efficacy and safety of intermittent intravenous outpatient administration of levosimendan in patients with advanced heart failure: the LION-HEART multicentre randomised trial.

Comín-Colet J, Manito N, Segovia-Cubero J, Delgado J, García Pinilla JM, Almenar L, Crespo-Leiro MG, Sionis A, Blasco T, Pascual-Figal D, Gonzalez-Vilchez F, Lambert-Rodríguez JL, Grau M, Bruguera J; LION-HEART Study Investigators.

Eur J Heart Fail. 2018 Jul;20(7):1128-1136. doi: 10.1002/ejhf.1145. Epub 2018 Feb 6.

PMID:
29405611
3.

Long-term Follow-up of Symptomatic Adult Patients With Noncompaction Cardiomyopathy.

Salazar-Mendiguchía J, González-Costello J, Oliveras T, Gual F, Lupón J, Manito N.

Rev Esp Cardiol (Engl Ed). 2017 Dec 27. pii: S1885-5857(17)30587-X. doi: 10.1016/j.rec.2017.11.021. [Epub ahead of print] English, Spanish. No abstract available.

PMID:
29289512
4.

Design of a multicentre randomized controlled trial to assess the safety and efficacy of dose titration by specialized nurses in patients with heart failure. ETIFIC study protocol.

Oyanguren J, García-Garrido L, Nebot Margalef M, Lekuona I, Comin-Colet J, Manito N, Roure J, Ruiz Rodriguez P, Enjuanes C, Latorre P, Torcal Laguna J, García-Gutiérrez S; ETIFIC7 research group.

ESC Heart Fail. 2017 Nov;4(4):507-519. doi: 10.1002/ehf2.12152. Epub 2017 Apr 3. Review.

5.

Rationale and design of a multicentre, prospective, randomised, controlled clinical trial to evaluate the efficacy of the adipose graft transposition procedure in patients with a myocardial scar: the AGTP II trial.

Gastelurrutia P, Gálvez-Montón C, Cámara ML, Bustamante-Munguira J, García-Pavia P, Avanzas P, Alberto San Román J, Pascual-Figal D, Teresa E, Crespo-Leiro MG, Manito N, Núñez J, Fernández-Avilés F, Caballero Á, Teis A, Lupón J, Brugada R, Martín C, Silva J, Revilla-Orodea A, Cánovas SJ, Melero JM, Cuenca-Castillo JJ, Gonzalez-Pinto A, Bayes-Genis A.

BMJ Open. 2017 Aug 4;7(8):e017187. doi: 10.1136/bmjopen-2017-017187.

6.

Repetitive use of levosimendan in advanced heart failure: need for stronger evidence in a field in dire need of a useful therapy.

Pölzl G, Altenberger J, Baholli L, Beltrán P, Borbély A, Comin-Colet J, Delgado JF, Fedele F, Fontana A, Fruhwald F, Giamouzis G, Giannakoulas G, Garcia-González MJ, Gustafsson F, Kaikkonen K, Kivikko M, Kubica J, von Lewinski D, Löfman I, Malfatto G, Manito N, Martínez-Sellés M, Masip J, Merkely B, Morandi F, Mølgaard H, Oliva F, Pantev E, Papp Z, Perna GP, Pfister R, Piazza V, Bover R, Rangel-Sousa D, Recio-Mayoral A, Reinecke A, Rieth A, Sarapohja T, Schmidt G, Seidel M, Störk S, Vrtovec B, Wikström G, Yerly P, Pollesello P.

Int J Cardiol. 2017 Sep 15;243:389-395. doi: 10.1016/j.ijcard.2017.05.081. Epub 2017 May 23. Review.

7.

Dilated Cardiomyopathy and Hydroxychloroquine-induced Phospholipidosis: From Curvilinear Bodies to Clinical Suspicion.

Di Girolamo F, Claver E, Olivé M, Salazar-Mendiguchía J, Manito N, Cequier Á.

Rev Esp Cardiol (Engl Ed). 2018 Jun;71(6):491-493. doi: 10.1016/j.rec.2017.04.017. Epub 2017 May 18. English, Spanish. No abstract available.

PMID:
28528883
8.

Benefit of tolvaptan in the management of hyponatraemia in patients with diuretic-refractory congestive heart failure: the SEMI-SEC project.

Pose A, Almenar L, Gavira JJ, López-Granados A, Blasco T, Delgado J, Aramburu O, Rodríguez A, Manzano L, Manito N.

ESC Heart Fail. 2017 May;4(2):130-137. doi: 10.1002/ehf2.12124. Epub 2017 Jan 19.

9.

Hyponatraemia and congestive heart failure refractory to diuretic treatment. Utility of tolvaptan.

Pose A, Almenar L, Manzano L, Gavira JJ, López Granados A, Delgado J, Aramburu O, Arévalo JC, Méndez M, Comín J, Manito N.

Rev Clin Esp. 2017 Oct;217(7):398-404. doi: 10.1016/j.rce.2017.02.013. Epub 2017 Apr 1. English, Spanish.

PMID:
28372784
10.

Selection of the Best of 2016 in Mechanical Circulatory Support.

Sánchez-Enrique C, González-Costello J, Ariza-Solé A, Miralles A, Manito N, Cequier A.

Rev Esp Cardiol (Engl Ed). 2017 Apr;70(4):303-305. doi: 10.1016/j.rec.2016.12.022. English, Spanish. No abstract available.

PMID:
28347411
11.

Chronic total occlusion of an infarct-related artery: a new predictor of ventricular arrhythmias in primary prevention implantable cardioverter defibrillator patients.

Di Marco A, Anguera I, Teruel L, Dallaglio P, González-Costello J, León V, Nuñez E, Manito N, Gómez-Hospital JA, Sabaté X, Cequier Á.

Europace. 2017 Feb 1;19(2):267-274. doi: 10.1093/europace/euw009.

PMID:
28175266
12.

Consensus Document of the Spanish Society of Cardiology and the Spanish Society of Internal Medicine on the diagnosis and treatment of iron deficiency in heart failure.

Manito N, Cerqueiro JM, Comín-Colet J, García-Pinilla JM, González-Franco A, Grau-Amorós J, Peraira JR, Manzano L.

Rev Clin Esp. 2017 Jan - Feb;217(1):35-45. doi: 10.1016/j.rce.2016.08.001. Epub 2016 Sep 14. English, Spanish.

PMID:
27639407
13.

Management of cytomegalovirus infection in solid organ transplant recipients: SET/GESITRA-SEIMC/REIPI recommendations.

Torre-Cisneros J, Aguado JM, Caston JJ, Almenar L, Alonso A, Cantisán S, Carratalá J, Cervera C, Cordero E, Fariñas MC, Fernández-Ruiz M, Fortún J, Frauca E, Gavaldá J, Hernández D, Herrero I, Len O, Lopez-Medrano F, Manito N, Marcos MA, Martín-Dávila P, Monforte V, Montejo M, Moreno A, Muñoz P, Navarro D, Pérez-Romero P, Rodriguez-Bernot A, Rumbao J, San Juan R, Vaquero JM, Vidal E; Spanish Society of Transplantation (SET); Group for Study of Infection in Transplantation of the Spanish Society of Infectious Diseases and Clinical Microbiology (GESITRA-SEIMC); Spanish Network for Research in Infectious Diseases (REIPI).

Transplant Rev (Orlando). 2016 Jul;30(3):119-43. doi: 10.1016/j.trre.2016.04.001. Epub 2016 Apr 29. Review.

PMID:
27132815
14.

Contribution of Population Pharmacokinetics to Dose Optimization of Ganciclovir-Valganciclovir in Solid-Organ Transplant Patients.

Padullés A, Colom H, Bestard O, Melilli E, Sabé N, Rigo R, Niubó J, Torras J, Lladó L, Manito N, Caldés A, Cruzado JM, Grinyó JM, Lloberas N.

Antimicrob Agents Chemother. 2016 Mar 25;60(4):1992-2002. doi: 10.1128/AAC.02130-15. Print 2016 Apr.

15.

Twelve-month efficacy and safety of the conversion to everolimus in maintenance heart transplant recipients.

Manito N, Delgado JF, Crespo-Leiro MG, Arizón JM, Segovia J, González-Vílchez F, Mirabet S, Lage E, Pascual-Figal D, Díaz B, Palomo J, Rábago G, Sanz M, Blasco T, Roig E.

World J Transplant. 2015 Dec 24;5(4):310-9. doi: 10.5500/wjt.v5.i4.310.

16.

Health-related quality of life, social support, and caregiver burden between six and 120 months after heart transplantation: a Spanish multicenter cross-sectional study.

Delgado JF, Almenar L, González-Vilchez F, Arizón JM, Gómez M, Fuente L, Brossa V, Fernández J, Díaz B, Pascual D, Lage E, Sanz M, Manito N, Crespo-Leiro MG.

Clin Transplant. 2015 Sep;29(9):771-80. doi: 10.1111/ctr.12578. Epub 2015 Jul 14.

PMID:
26074358
17.

Update for 2014 on clinical cardiology, geriatric cardiology, and heart failure and transplantation.

Barón-Esquivias G, Manito N, López Díaz J, Martín Santana A, García Pinilla JM, Gómez Doblas JJ, Gómez Bueno M, Barrios Alonso V, Lambert JL.

Rev Esp Cardiol (Engl Ed). 2015 Apr;68(4):317-23. doi: 10.1016/j.rec.2014.12.008. Epub 2015 Mar 7. Review.

PMID:
25758161
18.

Spanish Heart Transplantation Registry. 25th official report of the Spanish Society of Cardiology Working Group on Heart Failure and Heart Transplantation (1984-2013).

González-Vílchez F, Gómez-Bueno M, Almenar L, Crespo-Leiro MG, Arizón JM, Palomo J, Delgado J, Roig E, Lage E, Manito N; Spanish Heart Transplantation Teams.

Rev Esp Cardiol (Engl Ed). 2014 Dec;67(12):1039-51. doi: 10.1016/j.rec.2014.09.005. Epub 2014 Nov 11.

PMID:
25455756
19.

Donor/recipient sex mismatch and survival after heart transplantation: only an issue in male recipients? An analysis of the Spanish Heart Transplantation Registry.

Martinez-Selles M, Almenar L, Paniagua-Martin MJ, Segovia J, Delgado JF, Arizón JM, Ayesta A, Lage E, Brossa V, Manito N, Pérez-Villa F, Diaz-Molina B, Rábago G, Blasco-Peiró T, De La Fuente Galán L, Pascual-Figal D, Gonzalez-Vilchez F; Spanish Registry of Heart Transplantation.

Transpl Int. 2015 Mar;28(3):305-13. doi: 10.1111/tri.12488. Epub 2014 Nov 27.

20.

Donor-transmitted malaria after heart transplant managed successfully with artesunate.

Sabé N, González-Costello J, Oriol I, Sánchez-Salado JC, Ortega S, Oliver E, Manito N, Carratalà J.

Transpl Infect Dis. 2014 Dec;16(6):999-1002. doi: 10.1111/tid.12299. Epub 2014 Oct 1.

PMID:
25272242

Supplemental Content

Loading ...
Support Center